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Abstract Peroxynitrite, a potent oxidising, nitrating and
hydroxylating agent, results from the reaction of nitric oxide
with superoxide. We show that peroxynitrite can be produced by
the action of a single enzyme, xanthine oxidoreductase (XOR), in
the presence of inorganic nitrite, molecular oxygen and a
reducing agent, such as pterin. The effects of oxygen concentra-
tion on peroxynitrite production have been examined. The
physiologically predominant dehydrogenase form of the enzyme
is more effective than the oxidase form under aerobic conditions.
It is proposed that XOR-derived peroxynitrite fulfils a bacter-
icidal role in milk and in the digestive tract. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
Peroxynitrite is a potent oxidising, nitrating and hydroxy-
lating agent, that has attracted increasing scienti¢c interest
over the last decade [1^3]. It can mediate the oxidation of a
range of biological molecules, including sulphydryl com-
pounds, lipids, proteins and DNA [4^8]. Although the precise
mechanisms may di¡er, this species is powerfully cytotoxic [9]
and is believed to contribute to tissue injury in a range of
human diseases [10]. A major source of peroxynitrite is the
di¡usion-limited reaction of nitric oxide (NO) with superoxide
anion [11]. Superoxide anion can occur as a consequence of
the activities of several enzymes, including mitochondrial oxi-
dases, xanthine oxidoreductase (XOR), or any one of various
NAD(P)H oxidases [12,13]. NO, on the other hand, is gener-
ally assumed to arise solely via NO synthase-catalysed oxida-
tion of arginine in the presence of NADPH and molecular
oxygen [14]. However, we have recently described an entirely
new route to NO, involving reduction of nitrates or nitrites,
catalysed by XOR [15^17].
XOR is a molybdo£avoprotein [18], existing as a homo-
dimer, each 147 kDa subunit of which contains one molybde-
num atom, one FAD and two Fe2S2 centres [18,19]. The en-
zyme has a wide speci¢city for reducing substrates, although
its conventionally accepted role is in purine catabolism, where
it catalyses the oxidation of hypoxanthine to xanthine and
xanthine to uric acid. In mammals, XOR occurs in two inter-
convertible forms, xanthine dehydrogenase (XDH, EC
1.1.1.204), which predominates in vivo, and xanthine oxidase
(XO, EC 1.1.3.22). Both forms of the enzyme can reduce
molecular oxygen, although only XDH can reduce NAD,
which is its preferred electron acceptor.
Reduction of oxygen leads to superoxide anion and hydro-
gen peroxide, and it is the potential to generate these reactive
oxygen species that has led to widespread interest in the en-
zyme as a pathogenic agent in many forms of ischaemia^re-
perfusion injury [20].
We initially reported that XO catalyses the reduction of the
nitrovasodilator, glyceryl trinitrate, inorganic nitrate and in-
organic nitrite to NO in the presence of NADH under hy-
poxic conditions [15]. Subsequently, we have investigated the
reactions involving inorganic nitrite in greater detail, deriving
steady-state kinetic parameters for XOR-catalysed generation
of NO, under anaerobic conditions, in the presence of either
NADH or xanthine as reducing substrate [16]. In the course
of these latter studies, we observed that, in the case of XO,
apparent production of NO decreased with increasing oxygen
tensions, consistent with reaction of NO with enzyme-gener-
ated superoxide. We now report the direct determination of
peroxynitrite generated as a result of these XOR-catalysed
reactions and show that XDH is much more e¡ective than
XO as a source of peroxynitrite under aerobic conditions.
2. Materials and methods
2.1. Reagents
Dithiothreitol was purchased from the Alexis Corp. Oxygen-free
nitrogen (6 50 ppm O2) and compressed air were from British Oxy-
gen Corporation. SIN-1 was purchased from Calbiochem reagents.
Superoxide dismutase (SOD) (bovine erythrocyte) and all other re-
agents, unless otherwise stated, were from Sigma^Aldrich Corp. Stock
solutions of dihydrorhodamine 123 (DHR) were made up to 10 mM
in acetonitrile and stored at 320‡C in air-tight containers protected
from light.
2.2. XOR
XO was puri¢ed from bovine milk as described by Godber et al.
[16], in yields of approximately 15 mg/l of fresh milk. Puri¢ed enzyme
was dialysed overnight into 50 mM Na/Bicine, pH 8.3, frozen drop-
wise in liquid nitrogen and stored at 370‡C until required. The en-
zyme showed A280/A450 5.0^5.2 and, following thawing, contained
s 97% oxidase activity, as determined by the method described below.
It contained 35^38% functional active sites, as judged by activity to
£avin ratio (AFR), assuming fully active enzyme has an AFR of 208
[21].
XDH was prepared by incubating XO in the presence of 10 mM
dithiothreitol at 37‡C for 1 h, followed by gel-¢ltration on a PD-10
desalting column (Pharmacia). XDH prepared in this manner con-
tained 10^15% oxidase activity, as determined by the method de-
scribed below.
Concentrations of enzyme were determined from the UV-visible
spectrum, by using an absorption coe⁄cient of 36 mM31 subunit
cm31 at 450 nm [18].
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The oxidase contents of XO or XDH were determined by measur-
ing the rate of oxidation of xanthine to uric acid spectrophotometri-
cally at 295 nm in a Cary 100 spectrophotometer, using an absorption
coe⁄cient of 9.6 mM31 cm31 [22]. Assays were performed at
25.0 þ 0.2‡C in air-saturated Na/Bicine bu¡er, pH 8.3, containing
100 WM xanthine. The sum of oxidase and dehydrogenase contents
was determined as above but in the presence of 0.5 mM NAD.
2.3. Determination of NO
NO generation was followed by using an ozone chemiluminescence
assay in a continuous £ow apparatus (Sievers NOA 280) as described
by Godber et al. [16]. Reactions were carried out at 25.0 þ 0.2‡C in
50 mM potassium phosphate bu¡er, pH 7.2, containing enzyme, so-
dium nitrite and pterin.
That detection of NO was independent of oxygen tension was
shown by the following control experiment. IDP-inhibited XO, which
catalyses production of NO but not superoxide (see [16] and Section
3), was incubated with nitrite and a reducing substrate. Rates of NO
production were found not to vary signi¢cantly as oxygen concentra-
tions varied between 0 and 240 WM.
2.4. Determination of peroxynitrite
Peroxynitrite production was determined by monitoring the oxida-
tion of 100 WM DHR to rhodamine spectrophotometrically at 500 nm
using an absorption coe⁄cient of 78.8 M31 cm31 [23]. Assays were
performed at 25.0 þ 0.2‡C in 50 mM potassium phosphate bu¡er, pH
7.2, containing pterin and sodium nitrite in a stoppered, stirred 1 ml
cuvette. Gas of de¢ned oxygen concentration was bubbled through
the solution at a depth of 1 mm and a rate of 100 ml/min. Reactions
were started by addition of pterin and background rates obtained in
the presence of nitrite and iodonium diphenyl (IDP, see Section 3)
were subtracted from the observed rates.
Crow [23] has demonstrated the speci¢city for peroxynitrite of the
DHR assay, which is una¡ected by NO, superoxide or hydrogen per-
oxide.
The e¡ect of molecular oxygen on the DHR assay was determined
as follows. Peroxynitrite was generated from the reaction of hydrogen
peroxide with nitrous acid and quanti¢ed spectrophotometrically as
described by Beckman et al. [24]. Responses in the DHR assay to a
standard amount of peroxynitrite were determined at di¡erent con-
centrations of oxygen, varying from 0 to 240 WM. Responses varied
linearly over this range, corresponding to an increase in molar e⁄-
ciency of rhodamine production from 32% to 45%. Rates of peroxy-
nitrite production were corrected accordingly.
2.5. Determination of oxygen concentrations
De¢ned concentrations of oxygen were obtained by mixing oxygen-
free nitrogen with air using Sierra mass £ow controllers (Sierra Instru-
ments Inc., Monterey, CA, USA). Dissolved oxygen concentrations
were checked by using a Clark type oxygen electrode, and were calcu-
lated assuming that air-saturated bu¡er corresponded to 240 WM.
3. Results
3.1. Peroxynitrite production catalysed by XOR in the presence
of pterin and inorganic nitrite
Previous studies of XOR-catalysed reduction of inorganic
nitrite [15,16] were done in the presence of xanthine or
NADH as reducing substrates. However, preliminary experi-
ments using a standard peroxynitrite generating system, SIN-1
[25], established that both urate and NADH acted as scav-
engers of peroxynitrite, invalidating their use in its assay. On
the other hand, neither pterin nor its oxidation product, iso-
xanthopterin, interfered signi¢cantly with the DHR assay.
Pterin was accordingly chosen as reducing substrate in the
present work.
Incubation of XOR with inorganic nitrite and pterin
showed rates of peroxynitrite production (Section 2) that
were proportional to concentration of enzyme and could be
completely inhibited by oxypurinol [26] or IDP [16,27], inhib-
itors of the molybdenum and FAD sites of the enzyme, re-
spectively (Fig. 1). Neither oxypurinol nor IDP inhibited per-
oxynitrite generation by SIN-1 in the same system.
The dependence of peroxynitrite production catalysed by
Fig. 1. Schematic representation of the redox centres of XOR. Most
reducing substrates, including pterin, donate electrons to the molyb-
denum site (Mo), following which electrons are rapidly distributed
between Mo, FAD and the two iron^sulphur centres (shown here as
a single site, Fe^S) [16]. Nitrite and molecular oxygen, reduced at
the Mo or FAD sites, respectively, e¡ectively compete for a com-
mon pool of electrons. The products, NO and superoxide, then re-
act at di¡usion limited rates to give peroxynitrite [11]. Oxypurinol
acts at the Mo site to inhibit both pterin oxidation and nitrite re-
duction. IDP acts at the FAD site inhibiting only reduction of mo-
lecular oxygen.
Fig. 2. Rates of peroxynitrite production versus oxygen concentra-
tion in the presence of XO (A) or XDH (B). XO (0.45 WM) or
XDH (0.2 WM) were incubated, in the presence of 80 mM sodium
nitrite and 100 WM DHR, in 50 mM potassium phosphate, pH 7.2,
at 25.0 þ 0.2‡C with varying concentrations of oxygen. Reactions
were started by the addition of 40 WM pterin. Peroxynitrite produc-
tion was determined by monitoring the oxidation of DHR at
500 nm, as described in Section 2. Values are means þ S.D. (n = 3).
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XO and by XDH at varying concentrations of oxygen are
shown respectively in Fig. 2A,B. The pro¢les for the two
forms of the enzyme di¡er markedly in that XO-catalysed
rates are slower and strongly inhibited at relatively low oxy-
gen concentrations. XDH-catalysed rates, on the other hand,
continue to increase up to approximately 200 WM oxygen.
3.2. NO production catalysed by XOR in the presence of pterin
and inorganic nitrite: e¡ect of SOD
The e¡ect of oxygen concentration on NO production cat-
alysed by XDH is shown in Fig. 3. Apparent (i.e. detectable)
production of NO decreases as oxygen tension increases, fall-
ing essentially to zero at 100 WM oxygen. In the presence of
4.14 WM SOD (200 U), however, NO production is seen to be
maintained at signi¢cant levels up to at least 240 WM oxygen.
With XO, in contrast, NO production, although essentially
the same as with XDH under anaerobic conditions, fell sharp-
ly with increasing oxygen, reaching zero at 5^6 WM oxygen in
the absence of SOD. In the presence of 4.14 WM SOD, levels
were higher but nevertheless reached zero at less than 40 WM
oxygen (data not shown).
4. Discussion
In our previous study of XO-catalysed reduction of inor-
ganic nitrite to NO, we brie£y reported that NO production
decreased with increasing concentrations of oxygen [16]. On
the basis of the e¡ects of SOD, we attributed these decreases
to reaction of NO with XO-generated superoxide and pre-
sumed that the product was peroxynitrite. We now report
direct demonstration of peroxynitrite production catalysed
by XO and, more e¡ectively, by XDH.
Peroxynitrite was determined by monitoring oxidation of
DHR by an essentially established procedure [23,28]. In the
previous work, referred to above, NADH and xanthine were
used as reducing substrates [16]. These, however, proved to be
impractical in the present studies because both NADH and
urate acted as scavengers of peroxynitrite. The problem with
urate has been noted previously [28] and surmounted by using
pterin instead of xanthine as reducing substrate [9]. The
present work con¢rmed that neither pterin nor its oxidation
product, isoxanthopterin, interfered in the peroxynitrite assay.
The molar e⁄ciency of rhodamine production in the DHR
assay was found to increase slightly as oxygen tensions in-
creased, consistent with the mechanism of peroxynitrite-in-
duced oxidation of DHR proposed by Kooy et al. [28], and
was taken into account in calculation of the rate of peroxy-
nitrite production (Section 2).
In the presence of pterin, inorganic nitrite and oxygen, XO
was found to catalyse production of peroxynitrite, the rate of
which peaked at approximately 7 WM oxygen and thereafter
decreased with increasing oxygen concentrations (Fig. 2A).
The behaviour of XDH in the corresponding system di¡ered
markedly, in that rates of peroxynitrite production continued
to increase up to approximately 200 WM oxygen, achieving
values some 2-fold higher than in the case of XO (Fig. 2B).
These di¡erences can be largely explained in terms of produc-
tion of NO, the essential precursor of peroxynitrite. Under
anaerobic conditions, rates of NO production in the presence
of XO or XDH are essentially comparable. As oxygen levels
increase, levels of NO fall much more rapidly in the case of
XO. In the presence of SOD, rates of NO production are
higher with both forms of the enzyme, consistent with remov-
al of superoxide, which reacts with NO. This reaction
(NO+O32 COONO
3) generates peroxynitrite. Indeed, for
XDH, the di¡erences between the two curves, with and with-
out SOD (Fig. 3), broadly correspond to the pro¢le of per-
oxynitrite production (Fig. 2B).
Clearly, the question arises as to why NO production falls
o¡ with increasing oxygen levels so much more quickly in the
case of XO. This can be at least qualitatively explained in
terms of competition between nitrite and molecular oxygen
for pterin-generated electrons (Fig. 1). It is well established
that reducing substrates, with the exception of NADH, donate
electrons to the molybdenum centre of XOR, while molecular
oxygen accepts electrons at the FAD site [18]. Inorganic ni-
trite, on the other hand, accepts electrons directly from the
molybdenum site [16]. XO [29] is known to reduce molecular
oxygen some six times faster than does XDH [30], implying
that XO will have less electrons available for reduction of
nitrite than will XDH; a situation that will be exacerbated
as oxygen tensions increase [31].
The salient observation is that in the presence of oxygen,
inorganic nitrite and a reducing substrate, both XO and
XDH, in e¡ect, catalyse the production of peroxynitrite.
Moreover, in the case of XDH, such production continues
at signi¢cant levels even at 240 WM oxygen (i.e. aerobic con-
ditions). Concerning the implications of these ¢ndings for the
vasculature, XOR is known to occur in endothelial cells, both
intra- and extracellularly [32], most probably as XDH or XO,
respectively [33]. Attention has also been increasingly directed
to circulating enzyme, levels of which are normally low [34]
but which can rise dramatically in a number of in£ammatory
disease states, particularly those involving liver damage [35^
37]. Peroxynitrite, from whatever source, has the capacity to
e¡ect endothelial injury [38] and may be seen as particularly
relevant to cardiovascular disease. Indeed, levels of both XOR
[39] and anti-XOR antibodies [40] are known to be elevated
in plasma of atherosclerosis patients and the presence of
the enzyme has been demonstrated in their vessel walls and
plaques [41,42].
We have previously made a case for a bactericidal role in
Fig. 3. Rates of NO production versus oxygen concentration in the
presence of XDH, with and without addition of SOD. XDH (68.2
nM) was incubated in the presence of 40 mM sodium nitrite and 40
WM pterin in 50 mM potassium phosphate bu¡er, pH 7.2, at
25.0 þ 0.2‡C with varying concentrations of oxygen without (a) and
with (b) addition of SOD (200 U/ml). NO production was moni-
tored in a chemiluminescence NO meter (Section 2). Values are
means þ S.D. Where error bars are not shown, their width is less
than that of the symbol.
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the digestive tract for XOR, present in intestinal epithelial
cells or, in the case of the neonate, derived from maternal
milk [16]. This case was based on the enzyme’s capacity to
generate NO. It was supported by literature reports that ni-
trite levels in the immediate vicinity of enteric bacteria could
achieve millimolar concentrations and that XOR has a⁄nity
for acidic polysaccharides such as occur in bacterial capsules.
Similar and even stronger arguments apply to XOR-derived
peroxynitrite, the bactericidal activities of which are better
known than those of NO [9]. Moreover, as shown here,
XDH, the predominant form both in intestinal epithelial cells
[33] and in freshly expressed milk [43], is capable of peroxy-
nitrite generation across a very wide range of oxygen tensions,
encompassing all situations likely to be encountered physio-
logically. These arguments potentially provide an answer to
the long-standing question as to the role of high levels of
XOR in milk from all sources.
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